✦ LIBER ✦

Aerosol therapy in cystic fibrosis: A survey of 54 CF centers

✍ Scribed by Petra Borsje; Johan C. de Jongste; Johan W. Mouton; Harm A.W.M. Tiddens

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 164 KB
Volume: 30
Category: Article
ISSN: 8755-6863
DOI: 10.1002/1099-0496(200011)30:5<368::aid-ppul2>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two novel null mutations in a Taiwanese

Two novel null mutations in a Taiwanese cystic fibrosis patient and a survey of East AsianCFTR mutations

✍ Wong, Lee-Jun C. ;Alper, �zg�l M. ;Wang, Bao-Tyan ;Lee, Mei-Hui ;Lo, Shin-Yu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 1 views

Aerosolized dornase alfa in cystic fibro

Aerosolized dornase alfa in cystic fibrosis: Is there a role in the management of patients with early obstructive lung disease?

✍ David E. Geller 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

Airway inflammation and infection are present in patients with mild lung disease in cystic fibrosis (CF), suggesting the need for early treatment. In a previously reported large multicenter trial, dornase alfa improved pulmonary function and decreased the need for hospitalization in patients with CF

Comparison of flutter device and chest p

Comparison of flutter device and chest physical therapy in the treatment of cystic fibrosis pulmonary exacerbation

✍ Magdalen Gondor; Patricia A. Nixon; Rebecca Mutich; Paul Rebovich; David M. Oren 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

Chest physiotherapy (CPT) is recommended for the clearance of bronchial secretions in the management of patients with cystic fibrosis (CF). The Flutter® valve (Scandipharm, Birmingham, AL) has been introduced as an alternative method to CPT for airway mucus clearance. The objective of this study was